Literature DB >> 15668108

Acrylamide and glycidamide: genotoxic effects in V79-cells and human blood.

Matthias Baum1, Evelyne Fauth, Silke Fritzen, Armin Herrmann, Peter Mertes, Karlheinz Merz, Melanie Rudolphi, Heinrich Zankl, Gerhard Eisenbrand.   

Abstract

Acrylamide (AA) can be formed in certain foods by heating, predominantly from the precursor asparagine. It is a carcinogen in animal experiments, but the relevance of dietary exposure for humans is still under debate. There is substantial evidence that glycidamide (GA), metabolically formed from AA by Cyp 2E1-mediated epoxidation, acts as ultimate mutagenic agent. We compared the mutagenic potential of AA and GA in V79-cells, using the hprt mutagenicity-test with N-methyl-N'-nitro-N-nitroso-guanidine (MNNG) as positive control. Whereas MNNG showed marked mutagenic effectivity already at 0.5 microM, AA was inactive up to a concentration of 10 mM. In contrast, GA showed a concentration dependent induction of mutations at concentrations of 800 microM and higher. Human blood was used as model system to investigate genotoxic potential in lymphocytes by single cell gel electrophoresis (comet assay) and by measuring the induction of micronuclei (MN) with bleomycin (BL) as positive control. AA did not induce significant genotoxicity or mutagenicity up to 6000 microM. With GA, concentration dependent DNA damage was observed in the dose range of 300-3000 microM after 4 h incubation. Significant MN-induction was not observed with AA (up to 5000 microM) and GA (up to 1000 microM), whereas BL (4 microM) induced significantly enhanced MN frequencies. Thus, in our systems GA appears to exert a rather moderate genotoxic activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668108     DOI: 10.1016/j.mrgentox.2004.11.007

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

Review 1.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

2.  Genotoxic effects of acrylamide and glycidamide in mouse lymphoma cells.

Authors:  Nan Mei; Jiaxiang Hu; Mona I Churchwell; Lei Guo; Martha M Moore; Daniel R Doerge; Tao Chen
Journal:  Food Chem Toxicol       Date:  2007-09-22       Impact factor: 6.023

3.  Crystal structure of glycidamide: the mutagenic and genotoxic metabolite of acryl-amide.

Authors:  Melanie N Hemgesberg; Thorsten Bonck; Karl-Heinz Merz; Yu Sun; Dieter Schrenk
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-07-22

4.  Occurrence of Acrylamide in breakfast cereals and biscuits available in Italy.

Authors:  R Capei; L Pettini; A Lo Nostro; G Pesavento
Journal:  J Prev Med Hyg       Date:  2015

5.  Glycidamide Promotes the Growth and Migratory Ability of Prostate Cancer Cells by Changing the Protein Expression of Cell Cycle Regulators and Epithelial-to-Mesenchymal Transition (EMT)-Associated Proteins with Prognostic Relevance.

Authors:  Titus Ime Ekanem; Chi-Chen Huang; Ming-Heng Wu; Ding-Yen Lin; Wen-Fu T Lai; Kuen-Haur Lee
Journal:  Int J Mol Sci       Date:  2019-05-04       Impact factor: 5.923

6.  Mutagenicity of acrylamide and glycidamide in human TP53 knock-in (Hupki) mouse embryo fibroblasts.

Authors:  David H Phillips; Volker M Arlt; Lisa Hölzl-Armstrong; Jill E Kucab; Sarah Moody; Edwin P Zwart; Lucie Loutkotová; Veronica Duffy; Mirjam Luijten; Gonçalo Gamboa da Costa; Michael R Stratton
Journal:  Arch Toxicol       Date:  2020-09-04       Impact factor: 5.153

Review 7.  Revisiting the evidence for genotoxicity of acrylamide (AA), key to risk assessment of dietary AA exposure.

Authors:  Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-03       Impact factor: 5.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.